PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times

Pharmacy Times Continuing Education Free Continuing Education By Pharmacists For Pharmacists https://www.pharmacytimes.org/topic?t=Podcast

All episodes

Best episodes

Seasons

Top 10 PTCE Pharmacy Connect | Pharmacy Times Episodes

Goodpods has curated a list of the 10 best PTCE Pharmacy Connect | Pharmacy Times episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to PTCE Pharmacy Connect | Pharmacy Times for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite PTCE Pharmacy Connect | Pharmacy Times episode by adding your comments to the episode page.

Multiple Myeloma: Pharmacists as Therapy Experts | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

07/29/22 • 32 min

Educational Objectives

Objective 1: Describe a strategy to mitigate potential adverse effects of MM therapies by altering the route of administration, dosing schedule, and use of supportive care medications

Kathryn Maples, PharmD, BCOP

Clinical Pharmacy Specialist, Multiple Myeloma

Winship Cancer Institute, Emory Healthcare

Atlanta, Georgia

Kathryn Maples, PharmD, BCOP, has the following relevant financial relationships with commercial interests to disclose:
Consultant: GlaxoSmithKline, Janssen, Karyopharm, Sanofi

Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity numbers 0290-0000-22-315-H01-P and 0290-0000-22-315-H01-T. The activity is available for CE credit through July 11, 2023.

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Examining the Treatment Landscape of Metastatic NSCLC Expressing the Targetable Mutations RET, MET, and KRAS | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

07/29/22 • 32 min

Educational Objectives • Review the targetable mutations RET, MET, and KRAS, including associated agents for the treatment of metastatic non-small cell lung cancer (NSCLC) • Discuss the ways a pharmacist may improve adherence, toxicity management, and outcomes for patients with metastatic NSCLC expressing RET, MET, and KRAS mutations Josiah D. Land, PharmD, BCOP Clinical Pharmacy Specialist – Thoracic Medical Oncology Department of Pharmacy Memorial Sloan Kettering Cancer Center New York, New York Josiah D. Land, PharmD, BCOP, has the following financial relationship with a commercial interest to disclose: Consultant (advisory board): Bristol Myers Squibb Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number0290-0000-22-388-H01-P. The activity is available for CE credit through July 29, 2023. This activity is supported by educational funding provided by Amgen. Learn more about your ad choices. Visit megaphone.fm/adchoices

Caring for Patients With Multiple Myeloma Through Pharmacist-Directed Supportive Care and Toxicity Management Strategies | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

07/22/22 • 32 min

Introduction of faculty and disclosures: Dr. Kathryn Maples is a clinical pharmacy specialist in multiple myeloma at the Winship Cancer Institute with Emory Healthcare in Atlanta, Georgia. Dr. Maples has the following relevant financial relationships with commercial interests to disclose: consultant for GlaxoSmithKline, Janssen, Karyopharm, and Sanofi. Accreditation and support statement: PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC https://www.pharmacytimes.org/courses/multiple-myeloma-recognizing-treatment-options Learn more about your ad choices. Visit megaphone.fm/adchoices

Challenges in Treatment of Desmoid Tumors and Managed Care Solutions | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

02/23/24 • 26 min

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education.

Title: Challenges in Treatment of Desmoid Tumors and Managed Care Solutions

Educational Objectives

• Recall the key characteristics of desmoid tumors (DT), including presentation, frequency, genetic mutations, development, and outlook for individual patients • Outline practical solutions to improve managed care-driven communication with health care providers and address the clinical and financial burden of unresectable, recurrent DT

Moderator:

Laura Bobolts, PharmD, BCOP

Senior Vice President of Clinical Strategy and Growth

OncoHealth

Plantation, Florida

Faculty:

Christy Harris, PharmD, BCOP, FHOPA

Clinical Pharmacy Specialist

Dana-Farber Cancer Institute

Associate Professor

Massachusetts College of Pharmacy and Health Sciences

Boston, Massachusetts

Christy Harris, PharmD, BCOP, FHOPA and Laura Bobolts, PharmD, BCOP have no financial relationships with commercial interests to disclose.

Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours (0.05 CEU) under the ACPE universal activity number 0290-0000-23-421-H01-P. The activity is available for CE credit through February 28, 2024.

This activity is supported by an educational grant from SpringWorks Therapeutics.

Use of Novel Therapies in Endometrial Cancer: Update for Managed Care | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

07/29/22 • 31 min

Accreditation and support statement: · PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. · This activity is supported by educational grant from GlaxoSmithKline. Objectives • Review the guideline-recommended role of immune-based therapies in the management of endometrial cancer. • Discuss access to care, cost of care and cost-effectiveness of Immune checkpoint inhibitors in the treatment of endometrial cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices

Chronic Lymphocytic Leukemia: Insights into the Pharmacist Role in Therapy Management

PTCE Pharmacy Connect | Pharmacy Times

06/30/22 • 26 min

Introduction of faculty and disclosures: Dr. Katherine Tobon is a clinical pharmacy specialist in malignant hematology with Moffitt Cancer Center in Tampa, Florida. Dr. Tobon has no relevant financial relationships with commercial interests to disclose. Accreditation and support statement: PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hours of knowledge-based credit. This activity is supported by an educational grant from Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Administered by Janssen Scientific Affairs, LLC and BeiGene, Ltd. Learn more about your ad choices. Visit megaphone.fm/adchoices

Seizure Clusters: A Review of New Drug Delivery Methods and Emerging Therapy Options | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

03/31/22 • 34 min

Educational Objectives Examine challenges in current treatment options for seizure clusters, including efficacy and safety, and differentiating routes of administration Highlight considerations in treatment of seizure clusters, including addressing barriers to treatment and providing patient counseling to improve outcomes Faculty: Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM Professor Departments of Pharmacotherapy & Outcomes Science and Neurosurgery Virginia Commonwealth University, Medical College of Virginia Richmond, Virginia Neurocritical Care Clinical Pharmacist Virginia Commonwealth University Health Richmond, Virginia Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FCCM, FNCS, MCCM, has the following relevant financial relationships with commercial interests to disclose: Grant/Research Support: Department of Defense Consultant: UCB, Chiesi, Marinus, Alexion, Ceribell Speakers Bureau: UCB, Chiesi Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-129-H01-P. The activity is available for CE credit through March 31, 2023. This activity is supported by an educational grant from Neurelis Inc. Gretchen M. Brophy, PharmD, BCPS, FCCP, FCCM, FNCS, MCCM is Professor of Pharmacotherapy & Outcomes Sciences and Neurosurgery at Virginia Commonwealth University (VCU) School of Pharmacy, Medical College of Virginia Campus. She is a Past President of the Neurocritical Care Society. Dr. Brophy’s research interests include neuropharmacotherapy, traumatic brain injury, biomarkers, hemostasis, stroke, and status epilepticus. Learn more about your ad choices. Visit megaphone.fm/adchoices

Setting the Scene in Myelofibrosis Treatment and Management | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

08/29/22 • 25 min

Educational Objective: Review the etiology and pathophysiology of myelofibrosis, including the World Health Organization classification and diagnostic criteria. Victoria Nachar, PharmD, BCOP Clinical Pharmacist Specialist, Hematology University of Michigan Rogel Cancer Center Clinical Assistant Professor University of Michigan College of Pharmacy Ann Arbor, Michigan Victoria Nachar, PharmD, BCOP, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-381-H01-P. The activity is available for CE credit through August 29, 2023. This activity is supported by an educational grant from Incyte Corporation. Learn more about your ad choices. Visit megaphone.fm/adchoices

Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

05/25/21 • 41 min

Implementing Digital Technology Tools within Health-Systems for Improving Adherence and Patient Support Educational Objectives: At the completion of this activity, participants will be able to: Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management. Anthony J. Perissinotti, PharmD, BCOP is a Clinical Pharmacist Specialist, Hematology and the Clinical Team Leader Hematology/Oncology as well as an Adjunct Clinical Assistant Professor at the University of Michigan - Michigan Medicine in Ann Arbor, Michigan He has no relevant financial relationships with commercial interests to disclose. PTCE is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours of knowledge-based credit. Click here to view the activity on the PTCE website and claim your credit: https://www.pharmacytimes.org/on-demand/bcell-malignancies-podcast-part2 This activity is supported by educational grants from Pharmacyclics LLC., an AbbVie Company and Janssen Biotech, Inc and Beigene. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Treatment Advancements in Atopic Dermatitis With JAK Inhibitors: Updates for Pharmacists | PTCE Pharmacy Connect

PTCE Pharmacy Connect | Pharmacy Times

11/30/22 • 31 min

The educational objectives are: • Review the pathophysiology of atopic dermatitis (AD) as well as the efficacy and safety data for topical JAK inhibitors that are approved and in development • Discuss the role of pharmacists as a part of the care team for patients with AD as well as the key counseling points and monitoring parameters Faculty: Dennis Williams Moderator: Jamie McConaha

Show more best episodes

FAQ

How many episodes does PTCE Pharmacy Connect | Pharmacy Times have?

PTCE Pharmacy Connect | Pharmacy Times currently has 43 episodes available.

What topics does PTCE Pharmacy Connect | Pharmacy Times cover?

The podcast is about Podcasts and Business.

What is the most popular episode on PTCE Pharmacy Connect | Pharmacy Times?

The episode title 'Treatment of Duchenne Muscular Dystrophy: Updates in Disease-Modifying Drugs | PTCE Pharmacy Connect' is the most popular.

What is the average episode length on PTCE Pharmacy Connect | Pharmacy Times?

The average episode length on PTCE Pharmacy Connect | Pharmacy Times is 34 minutes.

How often are episodes of PTCE Pharmacy Connect | Pharmacy Times released?

Episodes of PTCE Pharmacy Connect | Pharmacy Times are typically released every 19 days, 13 hours.

When was the first episode of PTCE Pharmacy Connect | Pharmacy Times?

The first episode of PTCE Pharmacy Connect | Pharmacy Times was released on Dec 22, 2020.

Show more FAQ

PTCE Pharmacy Connect | Pharmacy Times

Pharmacy Times

Top 10 PTCE Pharmacy Connect | Pharmacy Times Episodes

FAQ

How many episodes does PTCE Pharmacy Connect | Pharmacy Times have?

What topics does PTCE Pharmacy Connect | Pharmacy Times cover?

What is the most popular episode on PTCE Pharmacy Connect | Pharmacy Times?

What is the average episode length on PTCE Pharmacy Connect | Pharmacy Times?

How often are episodes of PTCE Pharmacy Connect | Pharmacy Times released?

When was the first episode of PTCE Pharmacy Connect | Pharmacy Times?

Comments